The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
How long do rapid diagnostic tests remain positive after anti-malarial treatment?
Open accessAbstract
BACKGROUND: Rapid diagnostic tests (RDTs) are increasingly becoming a paradigm for both clinical diagnosis of malaria infections and for estimating community parasite prevalence in household malaria indicator surveys in malaria-endemic countries. The antigens detected by RDTs are known to persist in the blood after treatment with anti-malarials, but reports on the duration of persistence (and the effect this has on RDT positivity) of these antigens post-treatment have been variable. METHODS: In this review, published studies on the persistence of positivity of RDTs post-treatment are collated, and a bespoke Bayesian survival model is fit to estimate the number of days RDTs remain positive after treatment. RESULTS: Half of RDTs that detect the antigen histidine-rich protein II (HRP2) are still positive 15 (5-32) days post-treatment, 13 days longer than RDTs that detect the antigen Plasmodium lactate dehydrogenase, and that 5% of HRP2 RDTs are still positive 36 (21-61) days after treatment. The duration of persistent positivity for combination RDTs that detect both antigens falls between that for HRP2- or pLDH-only RDTs, with half of RDTs remaining positive at 7 (2-20) days post-treatment. This study shows that children display persistent RDT positivity for longer after treatment than adults, and that persistent positivity is more common when an individual is treated with artemisinin combination therapy than when treated with other anti-malarials. CONCLUSIONS: RDTs remain positive for a highly variable amount of time after treatment with anti-malarials, and the duration of positivity is highly dependent on the type of RDT used for diagnosis. Additionally, age and treatment both impact the duration of persistence of RDT positivity. The results presented here suggest that caution should be taken when using RDT-derived diagnostic outcomes from cross-sectional data where individuals have had a recent history of anti-malarial treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
Bhatt, S., Weiss, D. J., Cameron, E., Bisanzio, D., Mappin, B., Dalrymple, U., Battle, K. E., Moyes, C. L., Henry, A., Eckhoff, P. A., et al. (2015) · Nature · doi:10.1038/nature15535 · Cited by 3,225 · cited 1×
“These data from national surveys have been used to produce spatiotemporal maps of malaria prevalence and mortality at a continental scale [6, 7] (after careful standardization across different diagnostic methods [8]), to estimate the proportion of febrile illness in African children that is attributable to malaria ver…”
MethodSelf-citationOkell, L. C., Ghani, A. C., Lyons, E., & Drakeley, C. J. (2009) · The Journal of Infectious Diseases · doi:10.1086/644781 · Cited by 532
Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria
Mayxay, M., Pukrittayakamee, S., Chotivanich, K., Looareesuwan, S., & White, N. J. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90156-7 · Cited by 175
Mens, P., Spieker, N., Omar, S., Heijnen, M., Schallig, H., & Kager, P. A. (2007) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01779.x · Cited by 116
Tjitra, E., Suprianto, S., McBroom, J., Currie, B. J., & Anstey, N. M. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.1025-1031.2001 · Cited by 113 · cited 3×
“comparing sulfadoxine-pyrimethamine and artesunate with sulfadoxine-pyrimethamine (AS-SP) which found that AS-SP had approximately one-third fewer persistently positive RDTs in the first 7 days after treatment, and then roughly equivalent rates [42].”
MethodResult
Cited by
Watson, O. J., Sumner, K. M., Janko, M., Goel, V., Winskill, P., Slater, H. C., Ghani, A., Meshnick, S. R., & Parr, J. B. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2019-001582 · Cited by 99
“Treated patients may maintain detectable levels of HRP2 for months after parasite clearance, which can lead to overtreatment and the misdiagnosis of the true cause of symptoms.(4) False-negative (FN) results due to RDT failure, RDT misuse or misinterpretation of test bands can also result in discordance between the ou…”
Sternberg, E. D., Cook, J., Alou, L. P. A., Assi, S. B., Koffi, A. A., Doudou, D. T., Aoura, C. J., Wolie, R. Z., Oumbouke, W. A., Worrall, E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00250-6 · Cited by 57
Kayiba, N. K., Yobi, D. M., Tchakounang, V. R. K., Mvumbi, D. M., Kabututu, P. Z., Devleesschauwer, B., Mukomena, E. S., DeMol, P., Hayette, M.-P., Mvumbi, G. L., et al. (2021) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2021.105009 · Cited by 22
Metadata
- Authors
- Dalrymple, U., Arambepola, R., Gething, P. W., & Cameron, E.
- Venue
- Malaria Journal
- Published
- 2018-06-08
- Volume
- 17
- Issue
- 1
- Pages
- 228-228
- ISSN
- 1475-2875 (ISSN-L)
- OpenAlex
- W2806462273
- Cited by
- 187
- References
- 5
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How long do rapid diagnostic tests remain positive after anti-malarial treatment? https://app.cochat.ai/papers/10.1186/s12936-018-2371-9
- The paper
- Dalrymple, U., Arambepola, R., Gething, P. W., & Cameron, E. (2018). How long do rapid diagnostic tests remain positive after anti-malarial treatment? Malaria Journal. https://doi.org/10.1186/s12936-018-2371-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.